Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Iwona Solarska"'
Autor:
Jagoda Siemaszko, Piotr Łacina, Donata Szymczak, Agnieszka Szeremet, Maciej Majcherek, Anna Czyż, Małgorzata Sobczyk-Kruszelnicka, Wojciech Fidyk, Iwona Solarska, Barbara Nasiłowska-Adamska, Patrycja Skowrońska, Maria Bieniaszewska, Agnieszka Tomaszewska, Grzegorz W. Basak, Sebastian Giebel, Tomasz Wróbel, Katarzyna Bogunia-Kubik
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Transplantation of hematopoietic stem cells (HSCT) is a procedure commonly used in treatment of various haematological disorders which is associated with significantly improved survival rates. However, one of its drawbacks is the possibility of devel
Externí odkaz:
https://doaj.org/article/58bff34f811c4caa8bfad5c758ba0dca
Autor:
Marta Libura, Emilia Bialopiotrowicz, Sebastian Giebel, Agnieszka Wierzbowska, Gail J. Roboz, Beata Piatkowska-Jakubas, Marta Pawelczyk, Patryk Gorniak, Katarzyna Borg, Magdalena Wojtas, Izabella Florek, Karolina Matiakowska, Bozena Jazwiec, Iwona Solarska, Monika Noyszewska-Kania, Karolina Piechna, Magdalena Zawada, Sylwia Czekalska, Zoriana Salamanczuk, Karolina Karabin, Katarzyna Wasilewska, Monika Paluszewska, Elzbieta Urbanowska, Justyna Gajkowska-Kulik, Grazyna Semenczuk, Justyna Rybka, Tomasz Wrobel, Anna Ejduk, Dariusz Kata, Sebastian Grosicki, Tadeusz Robak, Agnieszka Pluta, Agata Kominek, Katarzyna Piwocka, Karolina Pyziak, Agnieszka Sroka-Porada, Anna Wrobel, Agnieszka Przybylowicz, Marzena Wojtaszewska, Krzysztof Lewandowski, Lidia Gil, Agnieszka Piekarska, Wanda Knopinska, Lukasz Bolkun, Krzysztof Warzocha, Kazimierz Kuliczkowski, Tomasz Sacha, Grzegorz Basak, Wieslaw Wiktor Jedrzejczak, Jerzy Holowiecki, Przemysław Juszczynski, Olga Haus
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) genes occur in about 20% patients with acute myeloid leukemia (AML), leading to DNA hypermethylation and epigenetic deregulation. We assessed the prognostic significance of IDH1/2 mutati
Externí odkaz:
https://doaj.org/article/4d3149eacd9c4e0bbd45e7fcb3834c44
Autor:
Aleksander Salomon-Perzyński, Joanna Barankiewicz, Marcin Machnicki, Irena Misiewicz-Krzemińska, Michał Pawlak, Sylwia Radomska, Agnieszka Krzywdzińska, Aleksandra Bluszcz, Piotr Stawiński, Małgorzata Rydzanicz, Natalia Jakacka, Iwona Solarska, Katarzyna Borg, Zofia Spyra-Górny, Tomasz Szpila, Bartosz Puła, Sebastian Grosicki, Tomasz Stokłosa, Rafał Płoski, Ewa Lech-Marańda, Jana Jakubikova, Krzysztof Jamroziak
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1674 (2022)
Clonal evolution drives treatment failure in multiple myeloma (MM). Here, we used a custom 372-gene panel to track genetic changes occurring during MM progression at different stages of the disease. A tumor-only targeted next-generation DNA sequencin
Externí odkaz:
https://doaj.org/article/157b567d61334d2ca4fc78ec78d72b72
Autor:
Anna Deręgowska, Monika Pępek, Iwona Solarska, Marcin M. Machnicki, Katarzyna Pruszczyk, Marek Dudziński, Joanna Niesiobędzka-Krężel, Ilona Seferyńska, Waldemar Sawicki, Maciej Wnuk, Tomasz Stokłosa
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Purpose Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by recurrent genetic aberration in leukemic stem cells, namely Philadelphia chromosome caused by reciprocal translocation t(9;22)(q34;q11). In our study, we analyze
Autor:
Elzbieta Patkowska, Alicja Sadowska-Klasa, Jan Zaucha, Andrzej Szczepaniak, Lidia Gil, Lukasz Bolkun, Michal Gorka, Marta Antonina Libura, Renata Guzicka-Kazimierczak, Marta Anna Sobas, Anna Koclega, Jolanta Wozniak, Krzysztof Lewandowski, Iwona Solarska, Magdalena Wojtas, Aleksandra Leszczynska, Zuzanna Kandula, Edyta Subocz, Edyta Cichocka, Katarzyna Krawczyk, Dorota Hawrylecka, Agnieszka Pluta, Agnieszka Wierzbowska, Sebastian Giebel, Ewa Lech-Marańda
Publikováno v:
Blood. 140:11836-11837
Publikováno v:
Hematologia. 11:253-258
The development of targeted therapies in AML patients enabling treatment individualization, such as new FLT3 tyrosine kinase inhibitors, is a promising option for improving treatment outcomes and prolonging patient survival. However, the treatment of
Autor:
Magdalena Zawada, Jerzy Holowiecki, Magdalena Wojtas, Sebastian Giebel, Agnieszka Przybylowicz, Anna Ejduk, I. Florek, Agnieszka Wierzbowska, Dariusz Kata, Kazimierz Kuliczkowski, Tomasz Wróbel, Beata Piatkowska-Jakubas, Przemysław Juszczynski, Marta Libura, Katarzyna Piwocka, Sylwia Czekalska, Marzena Wojtaszewska, Emilia Bialopiotrowicz, Karolina Matiakowska, Iwona Solarska, Tomasz Sacha, Patryk Gorniak, Tadeusz Robak, Elżbieta Urbanowska, Gail J. Roboz, Wiesław Wiktor Jędrzejczak, Agnieszka Sroka-Porada, Agnieszka Pluta, Wanda Knopinska, Justyna Gajkowska-Kulik, Krzysztof Warzocha, Anna Wróbel, Monika Paluszewska, Sebastian Grosicki, Karolina Karabin, Marta Pawelczyk, Bozena Jazwiec, Katarzyna Borg, Justyna Rybka, Grzegorz W. Basak, Olga Haus, Lidia Gil, Lukasz Bolkun, Agata Kominek, Grazyna Semenczuk, Agnieszka Piekarska, Krzysztof Lewandowski, Zoriana Salamanczuk, Karolina Pyziak, Katarzyna Wasilewska, Karolina Piechna, Monika Noyszewska-Kania
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) genes occur in about 20% patients with acute myeloid leukemia (AML), leading to DNA hypermethylation and epigenetic deregulation. We assessed the prognostic significance of IDH1/2 mutations (IDH1
Autor:
Aleksander, Salomon-Perzyński, Aleksandra, Bluszcz, Agnieszka, Krzywdzińska, Zofia, Spyra-Górny, Natalia, Jakacka, Joanna, Barankiewicz, Katarzyna, Borg, Iwona, Solarska, Tomasz, Szpila, Bartosz, Puła, Sebastian, Grosicki, Krzysztof, Jamroziak
Publikováno v:
Polish archives of internal medicine. 130(6)
Prognosis of patients with newly diagnosed multiple myeloma (MM), a third most common hematological cancer, is dependent on baseline cytogenetics. However, little is known about the prognostic significance of cytogenetic evolution (CE) at the time be
Autor:
Iwona Solarska, Aleksandra Bluszcz, Katarzyna Borg, Sebastian Grosicki, Zofia Spyra-Gorny, Krzysztof Jamroziak, Bartosz Pula, Natalia Jakacka, Tomasz Szpila, Joanna Barankiewicz, Aleksander Salomon-Perzyński, Agnieszka Krzywdzińska
Publikováno v:
Polish Archives of Internal Medicine.
Introduction Prognosis of patients with newly diagnosed multiple myeloma (MM), a third most common hematological cancer, is dependent on baseline cytogenetics. However, little is known about the prognostic significance of cytogenetic evolution (CE) a
Publikováno v:
Hematologia. 9:196-201
Light chain amyloidosis (AL amyloidosis) is a systemic disease leading to organ damage due to deposition of amyloid fibers arising from accumulation of amyloid precursors – monoclonal immunoglobulin light chains produced by clonal bone marrow plasm